Viewing Study NCT01645293


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2026-04-08 @ 11:56 AM
Study NCT ID: NCT01645293
Status: UNKNOWN
Last Update Posted: 2012-07-20
First Post: 2012-07-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis Fungoides
Sponsor: University of Cologne
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module